HNN3.0
Register
Register
Register

Project cooperationUpdated on 13 January 2026

Medical device industry partner

R&D Engineer at Boston Scientific

Clonmel, Ireland

About

Boston Scientific is one of the largest medical device companies in the world and has a long partnership with Ireland with over 4,500 employees based on the Island, distributed in three locations: Galway, Cork and Clonmel.

The Clonmel site have been involved in several previous Horizon projects and two that are currently ongoing.

Areas of interest:

Digital Manufacturing

Additive Manufacturing

Urology

Neuromodulation

Cardiac Rhythm Management

Boston Scientific Clonmel is the largest in terms of Value of Production in the worldwide Boston Scientific network of plants, being the sole manufacturer of all implantable electronics including Pacemakers, Cardiac Defibrillators and Neuromodulation devices. The Clonmel site has a long history of producing complex active electronic medical device implants and is engaged in all elements of Manufacturing (Quality, Research and Development, Product Performance, Engineering Operations, HR, Regulatory and Finance). The Process Development division within this site has been involved in numerous new product introductions and is the lead unit on site for both New Products, Technology, Prototype Development and Design for Manufacture. In addition to its core Process Development and R&D activities, the group has also dedicated Software, Electronic and Test Engineering Teams.

Expertise:

·         Dedicated prototyping laboratories

·         Full electrical test failure analysis, electrical test hardware, vision technology

·         Full production and process development dynamic environment with a multi-sided manufacturing process

·         Highly Accelerated Life Testing, Electrical Performance analysis.

·         Best in class epoxy dispense, wirebond and rework capability.

·         State of the art solder print, Pick & Place and inspection machines

·         Laser based and additive equipment

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices

Type

  • Partner seeks Consortium/Coordinator

Organisation

Boston Scientific

Company (Industry)

Clonmel, Ireland

Similar opportunities

  • Project cooperation

    Neuromodulation wearable platform for neurodegeneration.

    • Consortium/Coordinator seeks Partners
    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies

    patricia lecca

    CEO at NEUROCIA

    Toulouse, France

  • Project cooperation

    Early detection for heart diseases with AI

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Lorenzo Rindi

    Public Affairs Advisor at Lykke Advice

    Brussels, Belgium

  • Project cooperation

    Neuromodulation in Rehabilitation

    • Partner seeks Consortium/Coordinator
    • DESTINATION 6: HORIZON-HLTH-2026-01-IND-03: Regulatory science to support translational development of patient-centred health technologies
    • DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-02: Innovative interventions to prevent the harmful effects of using digital technologies on the mental health of children and young adults
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)

    Eugen Romulus Lontis

    Associate Professor at Aalborg University Hospital, Region North Denmark

    Aalborg, Denmark